nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—ALB—focal segmental glomerulosclerosis	0.615	1	CbGaD
Etodolac—SLC22A6—Cyclosporine—focal segmental glomerulosclerosis	0.129	0.685	CbGbCtD
Etodolac—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.059	0.315	CbGbCtD
Etodolac—UGT1A10—kidney—focal segmental glomerulosclerosis	0.00928	0.206	CbGeAlD
Etodolac—PTGS2—nephron—focal segmental glomerulosclerosis	0.00617	0.137	CbGeAlD
Etodolac—Uterine haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00568	0.045	CcSEcCtD
Etodolac—RXRA—kidney—focal segmental glomerulosclerosis	0.00553	0.123	CbGeAlD
Etodolac—Stomach ache—Cyclosporine—focal segmental glomerulosclerosis	0.00467	0.037	CcSEcCtD
Etodolac—UGT1A9—kidney—focal segmental glomerulosclerosis	0.00466	0.103	CbGeAlD
Etodolac—Leukorrhea—Cyclosporine—focal segmental glomerulosclerosis	0.00424	0.0336	CcSEcCtD
Etodolac—SLC22A6—nephron tubule—focal segmental glomerulosclerosis	0.00392	0.0871	CbGeAlD
Etodolac—UGT2B7—kidney—focal segmental glomerulosclerosis	0.00375	0.0834	CbGeAlD
Etodolac—Gastric ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00342	0.0271	CcSEcCtD
Etodolac—SLC22A6—cortex of kidney—focal segmental glomerulosclerosis	0.00336	0.0746	CbGeAlD
Etodolac—Vaginal discharge—Cyclosporine—focal segmental glomerulosclerosis	0.00327	0.0259	CcSEcCtD
Etodolac—PTGS1—endothelium—focal segmental glomerulosclerosis	0.00304	0.0676	CbGeAlD
Etodolac—Peptic ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00297	0.0235	CcSEcCtD
Etodolac—PTGS2—endothelium—focal segmental glomerulosclerosis	0.00291	0.0646	CbGeAlD
Etodolac—Burning sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00286	0.0227	CcSEcCtD
Etodolac—ALB—Scavenging of heme from plasma—APOL1—focal segmental glomerulosclerosis	0.00242	0.0935	CbGpPWpGaD
Etodolac—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.0022	0.0174	CcSEcCtD
Etodolac—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.00216	0.0171	CcSEcCtD
Etodolac—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00209	0.0165	CcSEcCtD
Etodolac—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.0155	CcSEcCtD
Etodolac—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.00188	0.0149	CcSEcCtD
Etodolac—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.00182	0.0144	CcSEcCtD
Etodolac—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00182	0.0144	CcSEcCtD
Etodolac—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.0018	0.0142	CcSEcCtD
Etodolac—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.0137	CcSEcCtD
Etodolac—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00169	0.0134	CcSEcCtD
Etodolac—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.013	CcSEcCtD
Etodolac—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.0128	CcSEcCtD
Etodolac—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.0128	CcSEcCtD
Etodolac—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.0127	CcSEcCtD
Etodolac—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00152	0.0121	CcSEcCtD
Etodolac—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00152	0.012	CcSEcCtD
Etodolac—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00151	0.012	CcSEcCtD
Etodolac—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.0119	CcSEcCtD
Etodolac—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.0118	CcSEcCtD
Etodolac—RXRA—Adipogenesis—ZMPSTE24—focal segmental glomerulosclerosis	0.00146	0.0566	CbGpPWpGaD
Etodolac—PTGS1—Overview of nanoparticle effects—COL4A1—focal segmental glomerulosclerosis	0.00143	0.0554	CbGpPWpGaD
Etodolac—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.0104	CcSEcCtD
Etodolac—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.0101	CcSEcCtD
Etodolac—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.00994	CcSEcCtD
Etodolac—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.00971	CcSEcCtD
Etodolac—PTGS1—kidney—focal segmental glomerulosclerosis	0.00122	0.0272	CbGeAlD
Etodolac—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.00968	CcSEcCtD
Etodolac—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.0095	CcSEcCtD
Etodolac—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.00947	CcSEcCtD
Etodolac—PTGS2—kidney—focal segmental glomerulosclerosis	0.00117	0.026	CbGeAlD
Etodolac—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.00923	CcSEcCtD
Etodolac—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.00912	CcSEcCtD
Etodolac—PTGS2—Overview of nanoparticle effects—COL4A1—focal segmental glomerulosclerosis	0.00114	0.044	CbGpPWpGaD
Etodolac—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00891	CcSEcCtD
Etodolac—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00886	CcSEcCtD
Etodolac—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.0011	0.00868	CcSEcCtD
Etodolac—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.00866	CcSEcCtD
Etodolac—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.00863	CcSEcCtD
Etodolac—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00858	CcSEcCtD
Etodolac—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00858	CcSEcCtD
Etodolac—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00856	CcSEcCtD
Etodolac—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.0084	CcSEcCtD
Etodolac—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.00826	CcSEcCtD
Etodolac—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.001	0.00794	CcSEcCtD
Etodolac—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.001	0.00792	CcSEcCtD
Etodolac—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.000997	0.0079	CcSEcCtD
Etodolac—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000997	0.0079	CcSEcCtD
Etodolac—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00099	0.00785	CcSEcCtD
Etodolac—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOL1—focal segmental glomerulosclerosis	0.000964	0.0373	CbGpPWpGaD
Etodolac—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000961	0.00762	CcSEcCtD
Etodolac—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00093	0.00737	CcSEcCtD
Etodolac—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000926	0.00734	CcSEcCtD
Etodolac—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000895	0.00709	CcSEcCtD
Etodolac—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000891	0.00706	CcSEcCtD
Etodolac—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000881	0.00699	CcSEcCtD
Etodolac—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000856	0.00678	CcSEcCtD
Etodolac—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000852	0.00675	CcSEcCtD
Etodolac—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00085	0.00674	CcSEcCtD
Etodolac—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000843	0.00668	CcSEcCtD
Etodolac—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000818	0.00648	CcSEcCtD
Etodolac—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000814	0.00645	CcSEcCtD
Etodolac—RXRA—YAP1- and WWTR1 (TAZ)-stimulated gene expression—CTGF—focal segmental glomerulosclerosis	0.00081	0.0313	CbGpPWpGaD
Etodolac—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000806	0.00638	CcSEcCtD
Etodolac—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000803	0.00636	CcSEcCtD
Etodolac—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000793	0.00629	CcSEcCtD
Etodolac—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000783	0.00621	CcSEcCtD
Etodolac—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00078	0.00618	CcSEcCtD
Etodolac—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000777	0.00616	CcSEcCtD
Etodolac—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000752	0.00596	CcSEcCtD
Etodolac—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00075	0.00594	CcSEcCtD
Etodolac—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000739	0.00586	CcSEcCtD
Etodolac—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000739	0.00586	CcSEcCtD
Etodolac—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000737	0.00584	CcSEcCtD
Etodolac—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00073	0.00579	CcSEcCtD
Etodolac—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000723	0.00573	CcSEcCtD
Etodolac—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000715	0.00566	CcSEcCtD
Etodolac—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000709	0.00562	CcSEcCtD
Etodolac—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000709	0.00562	CcSEcCtD
Etodolac—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000704	0.00558	CcSEcCtD
Etodolac—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000694	0.0055	CcSEcCtD
Etodolac—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000685	0.00543	CcSEcCtD
Etodolac—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000676	0.00535	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000646	0.00512	CcSEcCtD
Etodolac—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000641	0.00508	CcSEcCtD
Etodolac—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000636	0.00504	CcSEcCtD
Etodolac—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000632	0.00501	CcSEcCtD
Etodolac—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00063	0.00499	CcSEcCtD
Etodolac—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000624	0.00494	CcSEcCtD
Etodolac—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000616	0.00488	CcSEcCtD
Etodolac—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000611	0.00484	CcSEcCtD
Etodolac—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000606	0.0048	CcSEcCtD
Etodolac—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000606	0.0048	CcSEcCtD
Etodolac—RXRA—Recycling of bile acids and salts—ALB—focal segmental glomerulosclerosis	0.000593	0.023	CbGpPWpGaD
Etodolac—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000584	0.00463	CcSEcCtD
Etodolac—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00058	0.00459	CcSEcCtD
Etodolac—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000563	0.00446	CcSEcCtD
Etodolac—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00056	0.00444	CcSEcCtD
Etodolac—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00056	0.00444	CcSEcCtD
Etodolac—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000522	0.00414	CcSEcCtD
Etodolac—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000508	0.00403	CcSEcCtD
Etodolac—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000501	0.00397	CcSEcCtD
Etodolac—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL4A1—focal segmental glomerulosclerosis	0.000497	0.0192	CbGpPWpGaD
Etodolac—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000485	0.00384	CcSEcCtD
Etodolac—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000469	0.00371	CcSEcCtD
Etodolac—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000451	0.00357	CcSEcCtD
Etodolac—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000447	0.00354	CcSEcCtD
Etodolac—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000446	0.00354	CcSEcCtD
Etodolac—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000444	0.00352	CcSEcCtD
Etodolac—PTGS1—Overview of nanoparticle effects—FN1—focal segmental glomerulosclerosis	0.000442	0.0171	CbGpPWpGaD
Etodolac—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000421	0.00334	CcSEcCtD
Etodolac—RXRA—Vitamin A and Carotenoid Metabolism—LPL—focal segmental glomerulosclerosis	0.00041	0.0159	CbGpPWpGaD
Etodolac—ALB—Lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	0.000408	0.0158	CbGpPWpGaD
Etodolac—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	0.0004	0.0155	CbGpPWpGaD
Etodolac—ALB—Platelet degranulation—ACTN4—focal segmental glomerulosclerosis	0.000377	0.0146	CbGpPWpGaD
Etodolac—ALB—Response to elevated platelet cytosolic Ca2+—ACTN4—focal segmental glomerulosclerosis	0.000359	0.0139	CbGpPWpGaD
Etodolac—PTGS2—Overview of nanoparticle effects—FN1—focal segmental glomerulosclerosis	0.000351	0.0136	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000346	0.0134	CbGpPWpGaD
Etodolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—focal segmental glomerulosclerosis	0.000323	0.0125	CbGpPWpGaD
Etodolac—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	0.000318	0.0123	CbGpPWpGaD
Etodolac—RXRA—Bile acid and bile salt metabolism—ALB—focal segmental glomerulosclerosis	0.00031	0.012	CbGpPWpGaD
Etodolac—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—focal segmental glomerulosclerosis	0.000304	0.0118	CbGpPWpGaD
Etodolac—RXRA—PPARA activates gene expression—CTGF—focal segmental glomerulosclerosis	0.000279	0.0108	CbGpPWpGaD
Etodolac—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—focal segmental glomerulosclerosis	0.000273	0.0106	CbGpPWpGaD
Etodolac—ALB—Lipid and lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	0.000271	0.0105	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—COL4A1—focal segmental glomerulosclerosis	0.000264	0.0102	CbGpPWpGaD
Etodolac—RXRA—Transcriptional regulation of white adipocyte differentiation—LPL—focal segmental glomerulosclerosis	0.000257	0.00995	CbGpPWpGaD
Etodolac—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—focal segmental glomerulosclerosis	0.000254	0.00984	CbGpPWpGaD
Etodolac—ALB—Lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	0.000249	0.00964	CbGpPWpGaD
Etodolac—UGT1A9—PPARA activates gene expression—CTGF—focal segmental glomerulosclerosis	0.000243	0.0094	CbGpPWpGaD
Etodolac—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—focal segmental glomerulosclerosis	0.000238	0.0092	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000229	0.00884	CbGpPWpGaD
Etodolac—RXRA—Circadian Clock—SERPINE1—focal segmental glomerulosclerosis	0.000221	0.00856	CbGpPWpGaD
Etodolac—PTGS2—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	0.000219	0.00847	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—MYH10—focal segmental glomerulosclerosis	0.000219	0.00847	CbGpPWpGaD
Etodolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—focal segmental glomerulosclerosis	0.000213	0.00823	CbGpPWpGaD
Etodolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—focal segmental glomerulosclerosis	0.000209	0.00807	CbGpPWpGaD
Etodolac—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	0.000203	0.00786	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000195	0.00755	CbGpPWpGaD
Etodolac—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	0.000188	0.00728	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—LPL—focal segmental glomerulosclerosis	0.000169	0.00654	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	0.000167	0.00647	CbGpPWpGaD
Etodolac—ALB—Lipid and lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	0.000166	0.00641	CbGpPWpGaD
Etodolac—RXRA—PPARA activates gene expression—AGT—focal segmental glomerulosclerosis	0.000165	0.0064	CbGpPWpGaD
Etodolac—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	0.000164	0.00634	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.000162	0.00626	CbGpPWpGaD
Etodolac—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—focal segmental glomerulosclerosis	0.000162	0.00626	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.000149	0.00575	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—AGT—focal segmental glomerulosclerosis	0.000145	0.0056	CbGpPWpGaD
Etodolac—UGT1A9—PPARA activates gene expression—AGT—focal segmental glomerulosclerosis	0.000144	0.00557	CbGpPWpGaD
Etodolac—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—focal segmental glomerulosclerosis	0.000141	0.00545	CbGpPWpGaD
Etodolac—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	0.00014	0.00543	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000129	0.00498	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.000126	0.00486	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.00012	0.00464	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000116	0.00447	CbGpPWpGaD
Etodolac—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	0.000112	0.00431	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—SERPINE1—focal segmental glomerulosclerosis	0.000111	0.0043	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.000108	0.00418	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	0.000108	0.00417	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—SERPINE1—focal segmental glomerulosclerosis	0.000107	0.00415	CbGpPWpGaD
Etodolac—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—focal segmental glomerulosclerosis	0.000107	0.00413	CbGpPWpGaD
Etodolac—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	9.71e-05	0.00376	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	9.24e-05	0.00358	CbGpPWpGaD
Etodolac—ALB—Platelet degranulation—FN1—focal segmental glomerulosclerosis	8.99e-05	0.00348	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	8.91e-05	0.00345	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—SERPINE1—focal segmental glomerulosclerosis	8.73e-05	0.00338	CbGpPWpGaD
Etodolac—ALB—Hemostasis—ACTN4—focal segmental glomerulosclerosis	8.62e-05	0.00333	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	8.57e-05	0.00331	CbGpPWpGaD
Etodolac—ALB—Response to elevated platelet cytosolic Ca2+—FN1—focal segmental glomerulosclerosis	8.56e-05	0.00331	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	8.55e-05	0.00331	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	8.51e-05	0.00329	CbGpPWpGaD
Etodolac—UGT1A3—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	8.07e-05	0.00312	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	8.05e-05	0.00311	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	8.02e-05	0.0031	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	7.85e-05	0.00304	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	7.49e-05	0.0029	CbGpPWpGaD
Etodolac—ALB—Platelet degranulation—SERPINE1—focal segmental glomerulosclerosis	7.48e-05	0.00289	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	7.41e-05	0.00287	CbGpPWpGaD
Etodolac—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—focal segmental glomerulosclerosis	7.13e-05	0.00276	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—TGFB1—focal segmental glomerulosclerosis	7.02e-05	0.00272	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	6.93e-05	0.00268	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	6.89e-05	0.00266	CbGpPWpGaD
Etodolac—UGT2B7—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	6.86e-05	0.00265	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	6.71e-05	0.00259	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	6.52e-05	0.00252	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	6.51e-05	0.00252	CbGpPWpGaD
Etodolac—RXRA—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	6.4e-05	0.00248	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	6.04e-05	0.00234	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—LPL—focal segmental glomerulosclerosis	5.81e-05	0.00225	CbGpPWpGaD
Etodolac—ALB—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	5.77e-05	0.00223	CbGpPWpGaD
Etodolac—SLC22A6—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	5.59e-05	0.00216	CbGpPWpGaD
Etodolac—UGT1A9—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	5.57e-05	0.00216	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	5.32e-05	0.00206	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	5.19e-05	0.00201	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	5.19e-05	0.00201	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	5.16e-05	0.002	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	4.8e-05	0.00186	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—LIPC—focal segmental glomerulosclerosis	4.78e-05	0.00185	CbGpPWpGaD
Etodolac—ALB—Platelet degranulation—TGFB1—focal segmental glomerulosclerosis	4.72e-05	0.00183	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	4.52e-05	0.00175	CbGpPWpGaD
Etodolac—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—focal segmental glomerulosclerosis	4.5e-05	0.00174	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	4.44e-05	0.00172	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—CTGF—focal segmental glomerulosclerosis	4.29e-05	0.00166	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	4.28e-05	0.00165	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	4.22e-05	0.00163	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—CTGF—focal segmental glomerulosclerosis	4.2e-05	0.00163	CbGpPWpGaD
Etodolac—ALB—Hemostasis—TRPC6—focal segmental glomerulosclerosis	4.14e-05	0.0016	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	4.06e-05	0.00157	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—LIPC—focal segmental glomerulosclerosis	4.06e-05	0.00157	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	3.99e-05	0.00154	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—MMP2—focal segmental glomerulosclerosis	3.9e-05	0.00151	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.88e-05	0.0015	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.87e-05	0.0015	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.87e-05	0.0015	CbGpPWpGaD
Etodolac—RXRA—Metabolism—LIPC—focal segmental glomerulosclerosis	3.79e-05	0.00147	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.69e-05	0.00143	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	3.58e-05	0.00138	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CTGF—focal segmental glomerulosclerosis	3.58e-05	0.00138	CbGpPWpGaD
Etodolac—ALB—Hemostasis—GNAQ—focal segmental glomerulosclerosis	3.46e-05	0.00134	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.42e-05	0.00132	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	3.41e-05	0.00132	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CTGF—focal segmental glomerulosclerosis	3.33e-05	0.00129	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	3.32e-05	0.00128	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—LIPC—focal segmental glomerulosclerosis	3.3e-05	0.00128	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.29e-05	0.00127	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	3.24e-05	0.00125	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.18e-05	0.00123	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.15e-05	0.00122	CbGpPWpGaD
Etodolac—RXRA—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.07e-05	0.00119	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.97e-05	0.00115	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—MMP9—focal segmental glomerulosclerosis	2.93e-05	0.00113	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.93e-05	0.00113	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—LPL—focal segmental glomerulosclerosis	2.91e-05	0.00113	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	2.91e-05	0.00113	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CTGF—focal segmental glomerulosclerosis	2.91e-05	0.00112	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	2.84e-05	0.0011	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	2.8e-05	0.00108	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—LIPC—focal segmental glomerulosclerosis	2.69e-05	0.00104	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.68e-05	0.00104	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.5e-05	0.000969	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—AGT—focal segmental glomerulosclerosis	2.49e-05	0.000965	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—LPL—focal segmental glomerulosclerosis	2.48e-05	0.000959	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.42e-05	0.000936	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	2.41e-05	0.000934	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.37e-05	0.000916	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.37e-05	0.000916	CbGpPWpGaD
Etodolac—RXRA—Metabolism—LPL—focal segmental glomerulosclerosis	2.31e-05	0.000894	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.18e-05	0.000844	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—LIPC—focal segmental glomerulosclerosis	2.14e-05	0.000826	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—AGT—focal segmental glomerulosclerosis	2.12e-05	0.00082	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	2.09e-05	0.00081	CbGpPWpGaD
Etodolac—ALB—Hemostasis—FN1—focal segmental glomerulosclerosis	2.06e-05	0.000795	CbGpPWpGaD
Etodolac—ALB—Hemostasis—NOS2—focal segmental glomerulosclerosis	2.03e-05	0.000786	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.03e-05	0.000784	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—LPL—focal segmental glomerulosclerosis	2.01e-05	0.000779	CbGpPWpGaD
Etodolac—RXRA—Metabolism—AGT—focal segmental glomerulosclerosis	1.98e-05	0.000765	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	1.96e-05	0.000757	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.94e-05	0.00075	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.92e-05	0.000743	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—ALB—focal segmental glomerulosclerosis	1.91e-05	0.00074	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CTGF—focal segmental glomerulosclerosis	1.88e-05	0.000727	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.73e-05	0.00067	CbGpPWpGaD
Etodolac—ALB—Metabolism—LIPC—focal segmental glomerulosclerosis	1.73e-05	0.000668	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—AGT—focal segmental glomerulosclerosis	1.72e-05	0.000667	CbGpPWpGaD
Etodolac—ALB—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	1.71e-05	0.000662	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.66e-05	0.000641	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—LPL—focal segmental glomerulosclerosis	1.64e-05	0.000635	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—ALB—focal segmental glomerulosclerosis	1.63e-05	0.000629	CbGpPWpGaD
Etodolac—PTGS2—Disease—LPL—focal segmental glomerulosclerosis	1.56e-05	0.000602	CbGpPWpGaD
Etodolac—ALB—Metabolism—CTGF—focal segmental glomerulosclerosis	1.52e-05	0.000588	CbGpPWpGaD
Etodolac—RXRA—Metabolism—ALB—focal segmental glomerulosclerosis	1.52e-05	0.000587	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	1.41e-05	0.000547	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—AGT—focal segmental glomerulosclerosis	1.4e-05	0.000543	CbGpPWpGaD
Etodolac—ALB—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.4e-05	0.000542	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—ALB—focal segmental glomerulosclerosis	1.32e-05	0.000511	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—LPL—focal segmental glomerulosclerosis	1.3e-05	0.000504	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.27e-05	0.000492	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	1.25e-05	0.000482	CbGpPWpGaD
Etodolac—PTGS2—Disease—NOS2—focal segmental glomerulosclerosis	1.22e-05	0.00047	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.15e-05	0.000444	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—AGT—focal segmental glomerulosclerosis	1.11e-05	0.000431	CbGpPWpGaD
Etodolac—ALB—Hemostasis—TGFB1—focal segmental glomerulosclerosis	1.08e-05	0.000418	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ALB—focal segmental glomerulosclerosis	1.08e-05	0.000417	CbGpPWpGaD
Etodolac—ALB—Metabolism—LPL—focal segmental glomerulosclerosis	1.05e-05	0.000408	CbGpPWpGaD
Etodolac—PTGS2—Disease—SERPINE1—focal segmental glomerulosclerosis	1.02e-05	0.000396	CbGpPWpGaD
Etodolac—ALB—Metabolism—AGT—focal segmental glomerulosclerosis	9.02e-06	0.000349	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	8.63e-06	0.000334	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ALB—focal segmental glomerulosclerosis	8.56e-06	0.000331	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	7.38e-06	0.000286	CbGpPWpGaD
Etodolac—PTGS2—Disease—TGFB1—focal segmental glomerulosclerosis	6.46e-06	0.00025	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	5.67e-06	0.000219	CbGpPWpGaD
